![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PHF3 |
Gene summary for PHF3 |
![]() |
Gene information | Species | Human | Gene symbol | PHF3 | Gene ID | 23469 |
Gene name | PHD finger protein 3 | |
Gene Alias | PHF3 | |
Cytomap | 6q12 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | B3KP41 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23469 | PHF3 | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.73e-32 | -8.59e-01 | 0.0155 |
23469 | PHF3 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.44e-17 | -8.48e-01 | -0.1808 |
23469 | PHF3 | HTA11_2951_2000001011 | Human | Colorectum | AD | 3.07e-04 | -8.65e-01 | 0.0216 |
23469 | PHF3 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.53e-07 | -5.77e-01 | -0.0811 |
23469 | PHF3 | HTA11_78_2000001011 | Human | Colorectum | AD | 7.99e-03 | -4.83e-01 | -0.1088 |
23469 | PHF3 | HTA11_2112_2000001011 | Human | Colorectum | SER | 1.95e-03 | -8.49e-01 | -0.2196 |
23469 | PHF3 | HTA11_3361_2000001011 | Human | Colorectum | AD | 1.32e-16 | -9.05e-01 | -0.1207 |
23469 | PHF3 | HTA11_83_2000001011 | Human | Colorectum | SER | 9.51e-06 | -5.74e-01 | -0.1526 |
23469 | PHF3 | HTA11_696_2000001011 | Human | Colorectum | AD | 3.83e-24 | -7.08e-01 | -0.1464 |
23469 | PHF3 | HTA11_866_2000001011 | Human | Colorectum | AD | 1.57e-28 | -7.38e-01 | -0.1001 |
23469 | PHF3 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.02e-03 | -5.04e-01 | -0.059 |
23469 | PHF3 | HTA11_2992_2000001011 | Human | Colorectum | SER | 3.69e-04 | -7.89e-01 | -0.1706 |
23469 | PHF3 | HTA11_5212_2000001011 | Human | Colorectum | AD | 8.81e-03 | -6.45e-01 | -0.2061 |
23469 | PHF3 | HTA11_5216_2000001011 | Human | Colorectum | SER | 1.19e-03 | -8.65e-01 | -0.1462 |
23469 | PHF3 | HTA11_546_2000001011 | Human | Colorectum | AD | 3.53e-04 | -6.53e-01 | -0.0842 |
23469 | PHF3 | HTA11_9341_2000001011 | Human | Colorectum | SER | 5.49e-03 | -9.38e-01 | -0.00410000000000005 |
23469 | PHF3 | HTA11_7862_2000001011 | Human | Colorectum | AD | 1.05e-06 | -8.30e-01 | -0.0179 |
23469 | PHF3 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.80e-18 | -6.83e-01 | 0.096 |
23469 | PHF3 | HTA11_9408_2000001011 | Human | Colorectum | AD | 1.45e-06 | -1.03e+00 | 0.0451 |
23469 | PHF3 | HTA11_8622_2000001021 | Human | Colorectum | SER | 1.18e-03 | -7.61e-01 | 0.0528 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Oral cavity | OSCC | ![]() |
Oral cavity | LP | ![]() |
Oral cavity | EOLP | ![]() |
Oral cavity | NEOLP | ![]() |
Esophagus | HGIN | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PHF3 | SNV | Missense_Mutation | novel | c.3970N>T | p.His1324Tyr | p.H1324Y | Q92576 | protein_coding | tolerated(0.06) | probably_damaging(0.953) | TCGA-A2-A4RW-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
PHF3 | SNV | Missense_Mutation | c.1321N>A | p.Cys441Ser | p.C441S | Q92576 | protein_coding | tolerated_low_confidence(0.26) | benign(0.015) | TCGA-A7-A0DA-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
PHF3 | SNV | Missense_Mutation | c.4572A>C | p.Lys1524Asn | p.K1524N | Q92576 | protein_coding | deleterious(0) | benign(0.017) | TCGA-A8-A07R-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Ancillary | zoledronic | SD | |
PHF3 | SNV | Missense_Mutation | c.5560N>T | p.Pro1854Ser | p.P1854S | Q92576 | protein_coding | deleterious(0) | possibly_damaging(0.895) | TCGA-A8-A095-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR | |
PHF3 | SNV | Missense_Mutation | c.5465N>G | p.Asn1822Ser | p.N1822S | Q92576 | protein_coding | tolerated(0.09) | benign(0.009) | TCGA-A8-A09I-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | SD | |
PHF3 | SNV | Missense_Mutation | novel | c.1871A>G | p.Gln624Arg | p.Q624R | Q92576 | protein_coding | deleterious(0) | benign(0.255) | TCGA-AC-A2BK-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | cytoxan | CR |
PHF3 | SNV | Missense_Mutation | c.605G>A | p.Arg202Gln | p.R202Q | Q92576 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.518) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PHF3 | SNV | Missense_Mutation | novel | c.2444G>A | p.Arg815Lys | p.R815K | Q92576 | protein_coding | tolerated(1) | benign(0) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PHF3 | SNV | Missense_Mutation | rs764833590 | c.4973G>A | p.Arg1658Gln | p.R1658Q | Q92576 | protein_coding | deleterious(0) | benign(0.205) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PHF3 | SNV | Missense_Mutation | rs768248434 | c.6029G>A | p.Arg2010Gln | p.R2010Q | Q92576 | protein_coding | deleterious(0) | probably_damaging(0.926) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |